Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.58 |
| ▸ | PIP4K2A | P48426 | 6/20 | 0.57 |
| ▸ | TP53 | P04637 | 8/20 | 0.56 |
| ▸ | LMNA | P02545 | 8/20 | 0.56 |
| ▸ | SLC2A1 | P11166 | 2/20 | 0.49 |
| ▸ | SLC2A2 | P11168 | 2/20 | 0.49 |
| ▸ | SLC2A3 | P11169 | 2/20 | 0.49 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.44 |
| ▸ | PIP4K2C | Q8TBX8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25343885 | 0.90 | PIP4K2A (0.54) | MAPTPIP4K2ATP53LMNASLC2A1 | |
| SCHEMBL838951 | 0.84 | SLC2A1 (0.65) | MAPTTP53LMNASLC2A1SLC2A2 | |
| SCHEMBL25344401 | 0.82 | SLC2A1 (0.47) | MAPTPIP4K2ATP53LMNASLC2A1 | |
| SCHEMBL25344741 | 0.80 | SLC2A1 (0.56) | MAPTPIP4K2ATP53LMNASLC2A1 | |
| SCHEMBL839353 | 0.80 | TP53 (0.48) | MAPTPIP4K2ATP53LMNA | |
| SCHEMBL25341841 | 0.75 | SLC2A1 (0.42) | MAPTPIP4K2ATP53LMNASLC2A1 | |
| SCHEMBL29096496 | 0.74 | HTR3E (0.43) | MAPTPIP4K2ATP53LMNA | |
| SCHEMBL30639303 | 0.74 | HTR3E (0.43) | MAPTPIP4K2ATP53LMNA | |
| SCHEMBL6268329 | 0.73 | MAPT (0.64) | MAPTPIP4K2ATP53LMNAPIK3CG | |
| SCHEMBL11476904 | 0.73 | RAB9A (0.63) | MAPTTP53LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4472739-A1 | IMIDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE | F. Hoffmann-La Roche AG (CH) | 2024-12-11 | — | — | EP | disclosed |
| WO-2023148129-A1 | IMIDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE | F. HOFFMANN-LA ROCHE AG (CH) | 2023-08-10 | — | — | WO | disclosed |